Acceleron to Participate in Two Healthcare Investor Conferences in May
01 Mayo 2017 - 6:00AM
Business Wire
Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage
biopharmaceutical company focused on the discovery, development and
commercialization of innovative therapeutics to treat serious and
rare diseases, today announced that senior management will
participate in two upcoming healthcare investor conferences in
May.
Conference Details:
Event: Deutsche Bank 42nd Annual Health Care
Conference Date/Time: May 4, 2017 at 8:40 a.m. EDT Location:
Boston, MA Event: UBS Global Healthcare Conference
Date/Time: May 22, 2017 at 10:30 a.m. EDT Location: New York, NY
A live audio webcast for the Deutsche Bank and UBS Healthcare
Conferences will be available on the Investors/Media page of the
Company's website at www.acceleronpharma.com. A replay of the
webcast will be available approximately two hours after the event
on the Acceleron website.
About Acceleron
Acceleron is a clinical stage biopharmaceutical company focused
on the discovery, development and commercialization of innovative
therapeutics to treat serious and rare diseases. Its pioneering
research platform leverages the powerful biology behind the body’s
ability to rebuild and repair its own cells and tissues. This
approach to drug discovery has generated four therapeutic
candidates that are currently in clinical trials. The Company’s
lead therapeutic candidate, luspatercept, is being evaluated in
Phase 3 studies for the treatment of the hematologic diseases
myelodysplastic syndromes (MDS) and beta-thalassemia under a global
partnership with Celgene Corp. Acceleron is also advancing clinical
programs in the fields of oncology and neuromuscular diseases and
has a comprehensive preclinical research effort targeting fibrotic
and other serious diseases.
For more information, please visit www.acceleronpharma.com.
Follow Acceleron on Social
Media: @AcceleronPharma and LinkedIn.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170501005095/en/
Acceleron Pharma Inc.Todd James, IRC, 617-649-9393Senior
Director, Investor Relations and Corporate
CommunicationsorMedia:BMC CommunicationsBrad Miles,
646-513-3125
Acceleron Pharma (NASDAQ:XLRN)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Acceleron Pharma (NASDAQ:XLRN)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024
Real-Time news about Acceleron Pharma Inc (NASDAQ): 0 recent articles
Más de Acceleron Pharma Inc. (MM) Artículos de Noticias